Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2001 1
2007 1
2008 3
2009 4
2010 1
2011 2
2012 1
2013 5
2014 2
2015 5
2016 5
2017 4
2018 5
2019 6
2020 3
2021 4
2022 5
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study.
Oldgren J, Åsberg S, Hijazi Z, Wester P, Bertilsson M, Norrving B; National TIMING Collaborators. Oldgren J, et al. Among authors: bertilsson m. Circulation. 2022 Oct 4;146(14):1056-1066. doi: 10.1161/CIRCULATIONAHA.122.060666. Epub 2022 Sep 6. Circulation. 2022. PMID: 36065821 Free PMC article. Clinical Trial.
Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study.
Erlinge D, Maehara A, Ben-Yehuda O, Bøtker HE, Maeng M, Kjøller-Hansen L, Engstrøm T, Matsumura M, Crowley A, Dressler O, Mintz GS, Fröbert O, Persson J, Wiseth R, Larsen AI, Okkels Jensen L, Nordrehaug JE, Bleie Ø, Omerovic E, Held C, James SK, Ali ZA, Muller JE, Stone GW; PROSPECT II Investigators. Erlinge D, et al. Lancet. 2021 Mar 13;397(10278):985-995. doi: 10.1016/S0140-6736(21)00249-X. Lancet. 2021. PMID: 33714389
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.
IST-3 collaborative group; Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A. IST-3 collaborative group, et al. Lancet. 2012 Jun 23;379(9834):2352-63. doi: 10.1016/S0140-6736(12)60768-5. Epub 2012 May 23. Lancet. 2012. PMID: 22632908 Free PMC article. Clinical Trial.
Theorizing--for what?
Bertilsson M. Bertilsson M. Br J Sociol. 2016 Mar;67(1):30-5. doi: 10.1111/1468-4446.12187_2. Br J Sociol. 2016. PMID: 26948061 No abstract available.
Metabolic effects of furaldehydes and impacts on biotechnological processes.
Almeida JR, Bertilsson M, Gorwa-Grauslund MF, Gorsich S, Lidén G. Almeida JR, et al. Among authors: bertilsson m. Appl Microbiol Biotechnol. 2009 Mar;82(4):625-38. doi: 10.1007/s00253-009-1875-1. Epub 2009 Jan 31. Appl Microbiol Biotechnol. 2009. PMID: 19184597 Review.
Patient dissatisfaction with acute stroke care.
Asplund K, Jonsson F, Eriksson M, Stegmayr B, Appelros P, Norrving B, Terént A, Asberg KH; Riks-Stroke Collaboration. Asplund K, et al. Stroke. 2009 Dec;40(12):3851-6. doi: 10.1161/STROKEAHA.109.561985. Epub 2009 Oct 22. Stroke. 2009. PMID: 19850895
58 results